Denison Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Denison Pharmaceuticals's estimated annual revenue is currently $24.1M per year.
- Denison Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Denison Pharmaceuticals has 120 Employees.
- Denison Pharmaceuticals grew their employee count by 8% last year.
Denison Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Quality | Reveal Email/Phone |
2 | Associate Scientist II, R & D Analytical | Reveal Email/Phone |
Denison Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7M | 35 | 40% | N/A | N/A |
#2 | $11819.6M | 58804 | 2% | N/A | N/A |
#3 | $24.1M | 120 | 8% | N/A | N/A |
#4 | $3.2M | 16 | -43% | N/A | N/A |
#5 | $11.5M | 57 | 10% | N/A | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
What Is Denison Pharmaceuticals?
Meeting your stringent requirements doesn't mean much if the work isn't delivered on time and within budget. You'll find that our process at Denison Pharmaceuticals is the kind of efficient, personalized service our customers have come to depend on. Each product we manufacture has the safety, strength, and quality that it purports to possess. When you entrust the manufacturing of your pharmaceutical product to another company, you need people who share your demanding standard. For that kind of determined service, come to Denison Pharmaceuticals.
keywords:N/AN/A
Total Funding
120
Number of Employees
$24.1M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Denison Pharmaceuticals News
(Canada), Coveris Holdings S.A. (U.S.), Avery Denison Corporation (U.S.), Inc. (U.S.), Stickythings Limited (U.K.) and Inc. (U.S.). Compare Top...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $32.9M | 122 | 5% | N/A |
#2 | $27.3M | 124 | N/A | N/A |
#3 | $34M | 126 | 80% | N/A |
#4 | $20.9M | 128 | 6% | N/A |
#5 | $34.8M | 129 | 3% | N/A |